UltiMed acquired by LDI

MINNEAPOLIS — UltiMed — a manufacturer and distributor of pen needles, insulin syringes and other injection-related products — has been acquired by LDI, an Indianapolis-based family office that invests in growth-oriented businesses. 

 

UltiMed has been providing diabetic injection devices for more than 25 years, and its products are complemented by a dispense-and-dipose packaging system that lets patients easily and safely dispose of used sharps. 

 

“Our manufacturing business is a great fit with LDI,” said Jim Erickson, UltiMed president. “Our new relationship with LDI will give us greater resources to provide enhanced products and services. This will help our business partners and healthcare professionals better treat and manage the needs of their customers and patients. We welcome LDI’s experience in building businesses and their culture as a family office. We are excited to partner together to grow our business.”

 

The acquisition represents an exciting opportunity for LDI, which is led by president and CEO J.A. Lacy:  “Jim Erickson and the UltiMed management team have built a growing and profitable company based on high‐quality, user‐friendly products and a commitment to customer service,” Lacy said. “We are excited to work with the UltiMed team on a strategy to accelerate their growth and welcome them to the LDI family.”